Cardiovascular Indicators Surveillance Set Population-based Registers in Europe: results from the EUROCISS Project Agreement n° 2003118 Simona Giampaoli Istituto Superiore di Sanità, Rome, Italy 5° Meeting of the Task Force on Major and Chronic Diseases Luxembourg, 19 June 2007 Participating countries AUSTRIA K. Steinbach – Austrian Hearth Foundation, Wien BELGIUM M. Kornitzer – School of Public Health, Bruxelles CZECH REPUBLIC J. Holub – Institute of Health Information and Statistics, Praha DENMARK M. Madsen – National Institute of Public Health, Copenhagen FINLAND V. Salomaa – National Public Health Institute, Helsinki FRANCE J. Bloch – Institut de Veille Sanitarie, Saint Maurice GERMANY A. Doering – Insitute für Epidemiologie GSF, Neuherberg HUNGARY R. Adany – School of Public Health, Debrecen ITALY (coordinator) S. Giampaoli, L. Palmieri, P. Ciccarelli, S. Panico, D. Vanuzzo, Rome ICELAND V. Gudnason – Iceland Heart Association, Kopavogur GREECE A. Trichopoulou – School of Medicine, Athens The NETHERLANDS M. Verschuren – National Institute of Public Health and Environment, Bilthoven NORWAY S. Graff-Iversen – Norvegian Insitute of Public Health, Oslo POLAND A. Pajak – Institut of Public Health, Krakow PORTUGAL E. Rocha – Insituto de medicina Preventiva, Lisbon SPAIN S. Sans – Institut d'Estudis de la Salut, Barcelona SWEDEN N. Hammar – Karolinska Institute, Stockholm UK P. Primatesta – Univ. College London Medical School, London EUROPEAN HEART NETWORK S. Allender – University of Oxford, Oxford Main objectives To prioritise cardiovascular disease of major interest in EU countries To provide a list of recommended indicators and sources of information for monitoring CVD To prepare the Manual of Operations for the implementation of population-based registers of acute myocardial infarction/acute coronary syndrome, stroke and of CVD surveys Ca rdiova s cula r ndic I ators Su rveilla n c eSet Tools for monitoring cardiovascular disease Type of registers/health surveys Specific disease registers Registers based on routine administrative data Surveys Data sources Mortality HDR GP Records Mortality registers HDR Drug-dispensing registers Health interview and/or health examination Data collection Indicators fatal and non fatal events in and outside hospital by hot/cold pursuit Attack rate Incidence rate Prevalence Case fatality rate Treatment Years of life lived with disability (YLDS) Estimate of long-term care needs HDR and mortality data unlinked with or without validation Mortality Hospitalisation Length of stay HDR and mortality data linked with or without sample validation Questionnaire and medical examination of population samples Attack rate Case fatality rate Prevalence Risk factors Ca rdiova s cula r ndic I ators Su rveilla n c eSet NATIONAL AMI/ACS and STROKE Population-based Registers: population characteristics and case definition Country Age range Population (x 1000) ICD version Mortality ICD codes (*) HDR ICD codes (*) AMI/ACS Mortality ICD codes (+) HDS ICD codes (+) STROKE Denmark All 5,411 X 410-414, 798 410, 411, PTCA, CABG 430-438 430-438 Finland All 5,200 X 410-414, 428, 798, 799 410-414, 428, PTCA, CABG 430-438 430-438 Iceland 25-74 170 IX, X 410-414, 428, 798, 799 410-412, 414, PTCA, CABG Sweden All 9,011 X 410 410 430-434, 436-438 430-438 (*) all codes are presented in the ICD-9 revision to facilitate the comparison The EUROCISS Working Group. European J of Public Health 2003; 13 (Suppl 3): 55-60. Ca rdiova s cula r ndic I ators Su rveilla n c eSet REGIONAL AMI/ACS Population–based Registers: case definition ICD version Mortality ICD codes(*) HDR ICD codes(*) Linkage Mortality / HDR IX, X 410-414, 428, 798, 799 410-414, 428 PTCA, CABG Name, date of birth Northern Denmark X 410 410 PIN - Finland X 410, 411, 428, 798, 799 410, 411 PTCA, CABG PIN - France IX, X 410-414, 428, 798, 799, others 410-414, 428 Name, date of birth MONICA Germany X 410-414, 798, 799 410, 411 PTCA, CABG Name, date of birth MONICA, ESC/ACC Italy IX 410-414, 798, 799, others 410-414 Name, date of birth MONICA Norway X 410 410 PTCA, CABG PIN Spain IX 410-414, 428, 798, 799 410-414 Name, date of birth MONICA Northern Sweden – MONICA X 410, 411 410, 411 PIN MONICA Country Belgium Validation ECG, enzymes, symptoms, MONICA - (*) all codes are presented in the ICD-9 revision to facilitate the comparison The EUROCISS Working Group. European J of Public Health 2003; 13 (Suppl 3): 55-60. Ca rdiova s cula r ndic I ators Su rveilla n c eSet REGIONAL Stroke Population–based Registers: case definition Country Finland ICD version Mortality ICD codes HDR ICD codes Linkage Mortality / HDR X 430-432, 435, 436 430-432, 435, 436 PIN Validation MONICA WHO clinical criteria, CT-Scan or MRI France X 430-438, 442.81 430-438, 442.81 Name, date of birth Germany X 430-438 430-438 Name, date of birth CT-Scan, Health Insurance Italy MONICA IX 430-434, 436-438 430-434, 436-438 Name, date of birth MONICA Norway X 430-438 430-438 PIN MONICA Sweden MONICA X 430-438, 798, 799 430-438 PIN MONICA (*) all codes are presented in the ICD-9 revision to facilitate the comparison The EUROCISS Working Group. European J of Public Health 2003; 13 (Suppl 3): 55-60. Ca rdiova s cula r ndic I ators Su rveilla n c eSet ECHIM shortlist Suggestions from the EUROCISS Project - Attack rate as the most informative source of information for acute coronary and cerebrovascular events (it includes in- and out-ofhospital fatal and non-fatal first and recurrent events): data can be obtained through the population-based registers - Prevalence of ischemic heart disease and cerebrovascular accidents: data can be obtained through HIS/HES Ca rdiova s cula r ndic I ators Su rveilla n c eSet ECHIM shortlist Suggestions from the EUROCISS Project The manuals of operations produced by the EUROCISS Project describe the core indicators recommended by the Project and provide a simple guide and updated methods to support those EU countries lacking an appropriate cardiovascular surveillance systems but willing to implement a population-based register Ca rdiova s cula r ndic I ators Su rveilla n c eSet - AMI/ACS and Stroke Population-based Registers Manuals of Operations Objectives monitoring disease occurrence (attack and incidence rates) understanding differences between genders, age groups, social classes, ethnic groups, etc. identifying vulnerable groups monitoring in- and out-of-hospital case fatality monitoring the consequences of disease in terms of treatment and rehabilitation tracing the utilization and impact of new diagnostic tools and treatments Ca rdiova s cula r ndic I ators Su rveilla n c eSet – AMI/ACS and Stroke Population-based Registers Manuals of Operations Target population men and women aged 35-74 years well defined geographical area vital statistics routinely collected and easily available each year Completeness and representativeness Minimum of 300 fatal events every year Ca rdiova s cula r ndic I ators Su rveilla n c eSet – AMI/ACS and Stroke Population-based Registers Manuals of Operations Data sources Minimum sources of information required: mortality record with causes of death hospitalised discharge records with clinical information from cardiology, heart surgery, intensive care, medical, rehabilitation, neurological/neurosurgical, stroke, other (e.g. radiology) units nursing home and clinic autopsy register emergency and ambulance service (General Practitioner) Ca rdiova s cula r ndic I ators Su rveilla n c eSet – AMI/ACS and Stroke Population-based Registers Manuals of Operations Onset and survival First ever or recurrent event, with non-fatal and fatal outcome: first ever event refers to people who have never had an event before recurrent event: for a new episode occurring after 28 days from onset. Onset is day 1 Non-fatal event: refers to patients surviving at least 28 days after the symptoms onset Fatal event: refers to an event causing death within 28 days of symptoms onset Ca rdiova s cula r ndic I ators Su rveilla n c eSet – AMI/ACS and Stroke Population-based Registers Manuals of Operations Identification of events AMI/ACS Fatal events include: ICD9 codes 410-414 (ICD10: I20-I25) as underlying cause of death Non-fatal events include: ICD9 codes 410-411 (ICD10: I20.0, I21-I22) as primary or secondary hospital discharge diagnosis STROKE Fatal events include: ICD-9 430, 431, 432, 434, 436 (ICD-10 I60, I61, I62, I64) as underlying cause of death Non-fatal events include the same codes as primary or secondary hospital discharge diagnosis Ca rdiova s cula r ndic I ators Su rveilla n c eSet – AMI/ACS and Stroke Population-based Registers Manuals of Operations Identification of events Record linkage between mortality and hospital discharge records: manual deterministic probabilistic Hot and cold pursuit approaches for detecting inhospital events Ca rdiova s cula r ndic I ators Su rveilla n c eSet – AMI/ACS and Stroke Population-based Registers Manuals of Operations Quality control Quality control is extremely important for a valid monitoring and comparison and depends: completeness of cases [out of area event] completeness of information Ca rdiova s cula r ndic I ators Su rveilla n c eSet – AMI/ACS and Stroke Population-based Registers Manuals of Operations Validation provides the means to: take into account bias from diagnostic practices and changes in coding systems trace the impact of new diagnostic tools and re-definition of events ensure data comparability within the register (i.e. different sub- populations, different time points, etc) ensure data comparability with other registers within and between countries Ca rdiova s cula r ndic I ators Su rveilla n c eSet – AMI/ACS and Stroke Population-based Registers Manuals of Operations Internal Validity Validation evaluates the sensitivity, specificity and predictive value of the registered diagnosis compared to a golden standard To validate coronary events, the MONICA diagnostic criteria or the New Criteria of the Joint ESC/ACC may be applied as golden standard To validate stroke, MONICA criteria may be applied as golden standard Ca rdiova s cula r ndic I ators Su rveilla n c eSet – AMI/ACS and Stroke Population-based Registers Manuals of Operations External Validity All events occurring in the target population must be registered It is important to know how representative the register is for the whole country according to: Ischemic heart disease mortality rate distribution of risk factors (socioeconomic status and health behaviour) distribution of health service (specialized hospitals, GPs) Ca rdiova s cula r ndic I ators Su rveilla n c eSet EUROCISS recommends Population-based Registers STEPWISE Procedure STEP 1, Target population and routine data: select a geographical administrative area (e.g. with a stable population big enough to collect more than 300 events for ICD-9 410-414 in the age range 35-74), check the availability of hospital discharge records and death certificates with underlying and secondary causes of death, identify problems with these data STEP 2, Pilot study and validation of routine data: estimate coverage, validate discharge diagnoses and mortality causes, analyze demography and representativeness STEP 3, Record linkage: explore the feasibility of record linkage a) within Hospital Records, b) between Hospital Records and Mortality Register, c) with other sources of information (GPs) STEP 4, Set up a population-based register STEP 5, Analyse and disseminate the data from the register Ca rdiova s cula r ndic I ators Su rveilla n c eSet CVD Surveys – Manuals of Operations Stepwise procedure for HIS/HES Level of recommendation Health Examination Survey (HES) Minimum data collection Height Weight Blood pressure Waist circumference Non-fasting blood sample (Total cholesterol, HDL cholesterol, glucose…) Health Interview Survey (HIS) Age Sex Ethnicity Social class indicator (income, education, occupation) Smoking Angina qus Previous MI qus Previous stroke qus Diabetes Medication use Minimum + 1 The above plus Fasting blood sample (e.g. for fasting glucose) ECG Ankle/ brachial index Clinical exam. for HF The above plus Physical activity Diet Alcohol Heart failure qus Rose questionnaire Minimum + 2 The above plus Echocardiography The above plus Family history Quality of life Use of health services Minimum + 3 The above plus Ultrasound of peripheral arteries Other items pertaining to research question The above plus PAD questions Parity Other items pertaining to res qus Ca rdiova s cula r ndic I ators Su rveilla n c eSet Conclusions Ca rdiova s cula r ndic I ators Su rveilla n c eSet CVD are responsible of a great number of hospitalisation and deaths Many sources of information must be integrated, including population-based registers and HIS/HES A surveillance system based on the collection of comparable and valid data is essential for evaluating the burden of CVD, time trends and geographical distribution and for planning and implementing appropriate preventive actions http://www.cuore.iss.it/eurociss/en/progetto/progetto.asp